Advertisement
Top bosses at drugs firm Novavax pocket £34m windfall as Covid-19 vaccine enters late-stage trials
Novavax chief executive Stanley Erck and three of his colleagues offloaded the stock in a series of transactions since the start of 2020, capitalising on a near-3,000 per cent rise in the share price.
Read full story
Like CommentShare
Advertisement
Comments
No comments yet...